Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Veery
13F-HR - Veery Capital, LLC (0001844375) (Filer)

Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Veery Capital, LLC....

Platt
13F-HR - Platt Investment Counsel, LLC (0001859195) (Filer)

Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Platt Investment Counsel, LLC....

FSA
13F-HR - FSA Investment Group, LLC (0002051584) (Filer)

Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by FSA Investment Group, LLC....

PUFF
13F-HR - PUFF WEALTH MANAGEMENT, LLC (0002052736) (Filer)

Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by PUFF WEALTH MANAGEMENT, LLC....

AIB
AIB Data Centers issues CEO letter highlighting CLT1 development strategy

The company announced a 12-year agreement with Nebius for 50MW at its CLT1 campus and stated that customer prepayments will fund the initial developme...

WINEBRENNER
13F-HR - WINEBRENNER CAPITAL MANAGEMENT LLC (0002047728) (Filer)

Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by WINEBRENNER CAPITAL MANAGEMENT LLC....

Ellington
EFC declares monthly dividend

Ellington Financial Inc. declared a monthly dividend of $0.13 per share, payable November 30, 2026, for shareholders of record October 30, 2026....

Ellington
Ellington declares $0.08 monthly distribution

Ellington Credit declared a monthly common distribution of $0.08 per share, payable November 30, 2026, to shareholders of record as of October 30, 202...

TaoWeave,
TaoWeave Portfolio Company Manako Labs Goes Live with Avia in France

Manako Labs, a TaoWeave portfolio company, has launched its Vision Agents at 124 unmanned fuel stations in France. The deployment validates TaoWeave's...

CERO
CERO Therapeutics Sells U.S. Subsidiary to SRX Global

CERO Therapeutics entered into a definitive stock purchase agreement to sell its subsidiary CERO Therapeutics, Inc. to SRX Global for shares of SRX co...

Beeline
BELENE to Host Q3 2026 Results Call

Beeline Holdings announced it will hold a stakeholder call on Nov. 12 to review its Q3 2026 financial results and ongoing initiatives, providing insig...

Charlton
Charlton Aria enters business combination with KQC Quantum

Charlton Aria Acquisition Corp signed a definitive agreement to merge with KQC Quantum, Inc., to combine into a quantum computing company....

OpenWorld,
OpenWorld inks non-binding term sheet for $130M IP-backed deal

OpenWorld announced a non-binding term sheet to help BeyondAI structure a transaction up to $130 million backed by eligible patents, tokenized for inv...

MEXICO
Mexico Fund 30-day share volume at 26,315

The Mexico Fund reported total net assets of $329.90 million and an average daily share volume of 26,315. The Fund is trading at a 10.88% discount to ...

FUELCELL
CFO Colley's Departure and Advisory Role

FuelCell Energy announced CFO Michael Bishop will transition to an advisory role effective October 2026, with severance-eligible termination without c...

Jasper
Jasper Therapeutics Offers to Buy Outstanding Warrants

The Company is offering to purchase any and all outstanding warrants in an attempt to reduce dilution and set a clear capital structure, with the purc...

SRX
SRX in agreement to acquire controlling stake in CERo Therapeutics

SRX Global has executed a definitive agreement to purchase all shares of CERo Therapeutics Holdings, Inc., aiming to integrate its biotechnology opera...

WillScot
WillScot appoints Donald Slager to Board of Directors

WillScot Holdings Corp named Donald Slager to its Board of Directors, enhancing its governance with the former CEO of Republic Services. His appointme...

Dalrada
Dalrada signs settlement deal with IBS Funds

Dalrada Technology Group and IBS Equity and Credit Funds have signed a settlement agreement to resolve disputes related to Project RX financing, effec...

Spyre
Spyre Therapeutics to Offer 4.12M Firm Shares & Option for Up to 618K More in Public Offering

Spyre Therapeutics entered into an underwriting agreement to sell an aggregate of 4,117,648 shares of common stock, with an option for an additional 6...